AIMS: To evaluate 3 Bayesian forecasting (BF) programs-TDMx, InsightRx and DoseMe-on their user-friendliness and common liked and disliked features through a survey of hospital pharmacists. METHODS: Clinical pharmacists across 3 Australian hospitals that did not use a BF program were invited to a BF workshop and complete a survey on programs they trialled. Participants were given 4 case scenarios to work through and asked to complete a 5-point Likert scale survey evaluating the program's user-friendliness. Liked and disliked features of each program were ascertained through written responses to open-ended questions. Survey results were compared using a χ2 test of equal or given proportions to identify significant differences in response. RESULTS: Twenty-seven pharmacists, from hospitals, participated. BF programs were rated overall as user-friendly with 70%, 41% and 37% (P = .02) of participants recording a Likert score of 4 or 5 for DoseMe, TDMx and InsightRx, respectively. Participants found it easy to access all required information to use the programs, understood dosing recommendations and visualisations given by each program, and thought programs supported decision-making with >50% of participants scoring a 4 or 5 across the programs in these categories. Common liked features across all programs were the graphical displays and ease of data entry, while common disliked features were related to the units, layout and information display. CONCLUSION: Although differences exist between programs, all 3 programs were most commonly rated as user-friendly across all themes evaluated, which provides useful information for healthcare facilities wanting to implement a BF program.
AIMS: To evaluate 3 Bayesian forecasting (BF) programs-TDMx, InsightRx and DoseMe-on their user-friendliness and common liked and disliked features through a survey of hospital pharmacists. METHODS: Clinical pharmacists across 3 Australian hospitals that did not use a BF program were invited to a BF workshop and complete a survey on programs they trialled. Participants were given 4 case scenarios to work through and asked to complete a 5-point Likert scale survey evaluating the program's user-friendliness. Liked and disliked features of each program were ascertained through written responses to open-ended questions. Survey results were compared using a χ2 test of equal or given proportions to identify significant differences in response. RESULTS: Twenty-seven pharmacists, from hospitals, participated. BF programs were rated overall as user-friendly with 70%, 41% and 37% (P = .02) of participants recording a Likert score of 4 or 5 for DoseMe, TDMx and InsightRx, respectively. Participants found it easy to access all required information to use the programs, understood dosing recommendations and visualisations given by each program, and thought programs supported decision-making with >50% of participants scoring a 4 or 5 across the programs in these categories. Common liked features across all programs were the graphical displays and ease of data entry, while common disliked features were related to the units, layout and information display. CONCLUSION: Although differences exist between programs, all 3 programs were most commonly rated as user-friendly across all themes evaluated, which provides useful information for healthcare facilities wanting to implement a BF program.
Authors: Douglas S Wakefield; Jonathon R B Halbesleben; Marcia M Ward; Qian Qiu; Jane Brokel; Donald Crandall Journal: Med Care Date: 2007-09 Impact factor: 2.983
Authors: Catherine M DesRoches; Eric G Campbell; Sowmya R Rao; Karen Donelan; Timothy G Ferris; Ashish Jha; Rainu Kaushal; Douglas E Levy; Sara Rosenbaum; Alexandra E Shields; David Blumenthal Journal: N Engl J Med Date: 2008-06-18 Impact factor: 91.245
Authors: Johanna Kaipio; Tinja Lääveri; Hannele Hyppönen; Suvi Vainiomäki; Jarmo Reponen; Andre Kushniruk; Elizabeth Borycki; Jukka Vänskä Journal: Int J Med Inform Date: 2016-10-17 Impact factor: 4.046
Authors: Michael A Barras; David Serisier; Stefanie Hennig; Katrina Jess; Ross L G Norris Journal: Antimicrob Agents Chemother Date: 2016-10-21 Impact factor: 5.191
Authors: Alexandra Migga; Georg Schulz; Griffin Rodgers; Melissa Osterwalder; Christine Tanner; Holger Blank; Iwan Jerjen; Phil Salmon; William Twengström; Mario Scheel; Timm Weitkamp; Christian M Schlepütz; Jan S Bolten; Jörg Huwyler; Gerhard Hotz; Srinivas Madduri; Bert Müller Journal: J Med Imaging (Bellingham) Date: 2022-03-31